RBBIO

BridgeBio Pharma, Inc. rStock

76.15

16 sept., 13:41 UTC

Commercial-stage biopharmaceutical company focused on discovering and developing medicines for genetic diseases.

Données provenant de

+28.79%

Bitcoin$83,841.44

-0.65%

-3.54%

Definitive$0.09972334232

+19.94%

-2.31%

-9.14%

+10.34%

Ondo$0.53967

+4.40%

peaq$0.04061522229

-0.30%

Pepe$0.00000446484

-0.11%